| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/21/2006 | EP1670825A2 Antibodies to m-csf |
| 06/21/2006 | EP1670766A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases |
| 06/21/2006 | EP1670486A1 Treatment of a condition in a mammal with adminisration of aminosugar and uses thereof |
| 06/21/2006 | EP1670469A1 Use of known active ingredients as radical scavengers |
| 06/21/2006 | EP1506193B1 Carbamate-substituted pyrazolopyridines |
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1401415B1 Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases |
| 06/21/2006 | EP1392325B1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1284952B1 Substituted chalcones as therapeutic compounds |
| 06/21/2006 | EP1244647B1 Quinazoline derivatives as vegf inhibitors |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1150569B1 Method for reducing hip joint laxity |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791412A Novel compounds and their use in therapy |
| 06/21/2006 | CN1791404A Antiarthritic combinations |
| 06/21/2006 | CN1791393A Composition for inhibition or prevention of bone density lowering and refreshment therefor |
| 06/21/2006 | CN1791391A Composition containing higher fatty acid derivative and foods and drinks |
| 06/21/2006 | CN1789278A Osteoporosis resistant estrogen-RGD peptide conjugate and its application in medicine |
| 06/21/2006 | CN1788789A Anti-inflammatory action of oxidation type extrasin beta-10 |
| 06/21/2006 | CN1788787A Plaster for orthopaedics and its preparation method |
| 06/21/2006 | CN1788771A Chinese medicinal preparation for treating traumatic injury and its preparation process |
| 06/21/2006 | CN1788770A Numbness relieving and pain relieving ointment |
| 06/21/2006 | CN1788754A Oral medicine for treating hyperosteogeny-pellet for treating bone pain |
| 06/21/2006 | CN1788749A Preparation method of capsule containing red sage root and notoginseng |
| 06/21/2006 | CN1788739A Use of angelica oil in preparing drug for treating climacteric syndrome and osteoporosis |
| 06/21/2006 | CN1788611A Whole wood frog powder for removing fishy smell and its health product and its production method |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/21/2006 | CN1259949C Capsule for treating wound |
| 06/21/2006 | CN1259947C Bone fracture, injury capsule and its manufacturing method |
| 06/21/2006 | CN1259942C Medicament for treating osteoporosis and osteonecrosis |
| 06/21/2006 | CN1259940C Medicinal composition for treatnig bone fracture and its uses |
| 06/21/2006 | CN1259924C Chinese medicine for fracture and preparation thereof |
| 06/21/2006 | CN1259914C Use of scopoletin in preparing medicine for preventing and curing hyperuricemia |
| 06/21/2006 | CN1259903C Slow release bioadhesive buccal tablet |
| 06/20/2006 | US7064203 Di-substituted pyrrolotriazine compounds |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/20/2006 | US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents |
| 06/20/2006 | US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | CA2260423C Pharmaceutical composition of hedgehog proteins and use thereof |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062424A2 Use of 3-hydroxy-3-methylbutyrate alone or in combination with alpha-ketoglutarate in the growth and mineralisation of the osteo-skeletal system |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006062072A1 Remedy for cancer metastasis and cancer metastasis inhibitor |
| 06/15/2006 | WO2006061683A1 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteogenesis imperfecta |
| 06/15/2006 | WO2006060885A1 7-(2-cyclohexylidene-ethylidene)-spiro[5.5]undecanes useful for making pharmaceutical compositions |
| 06/15/2006 | WO2006060884A1 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes |
| 06/15/2006 | US20060129071 Method and apparatus for mechanical stimulation of tissue in vitro |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128737 Androgen receptor agonists |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128701 N-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenyl}-2-[4-(2-oxo-4H-benzo[d][1,3]oxazin-1- yl)-piperidin-1-yl]-acetamide; Eating disorders; CNS disorders; antidiabetic agents; psychological disorders; antiepileptic, antiinflammatory agents, autoimmune diseases; neuropeptide Y5 (NPY5) receptor antagonists |
| 06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/15/2006 | US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 06/15/2006 | US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 06/15/2006 | US20060128621 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/15/2006 | US20060127494 Biologically active products |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127450 Composition containing higher fatty acid derivative and foods and drinks |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127353 Fat-binding polymers |
| 06/15/2006 | CA2589274A1 Inhibitors of protein kinases |
| 06/15/2006 | CA2589271A1 Urea inhibitors of map kinases |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1669458A1 Process for producing 1,4-dihydoxy-2-naphthoic acid |
| 06/14/2006 | EP1669350A1 Novel piperidine derivative |
| 06/14/2006 | EP1669084A1 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669078A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside RB 1 |
| 06/14/2006 | EP1667692A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist |
| 06/14/2006 | EP1667691A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
| 06/14/2006 | EP1667690A1 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis |
| 06/14/2006 | EP1667689A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1393075A4 Methods of screening and using inhibitors of angiogenesis |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1349550B1 Substituted-4-quinolones for the treatment of autoimmune diseases |